Dual-Column LCMS Analysis Without Hydrolysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current chromatographic methods for analyzing drug compounds in biological specimens require hydrolysis steps, which are time-consuming and costly, and are not well-suited for routine clinical measurements in hospital labs, where the complex instrumentation is not typically available.
Innovation Solution
A method and apparatus using two chromatographic columns in a single LCMS run to trap and elute drug parent compounds and their metabolites separately, allowing for the calculation of total concentrations without the need for hydrolysis, implemented in an automated sample preparation and analysis system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If hydrolysis steps are used to convert metabolites back to parent compounds for quantification, then measurement accuracy is improved, but analysis time and operational complexity increase significantly
Solution Approach 1:
The patent divides the analysis into two separate chromatographic columns: a HILIC column that retains hydrophilic metabolites and a C18 column that retains parent compounds. This segmentation allows simultaneous detection of both metabolites and parent compounds without requiring hydrolysis conversion, thereby maintaining measurement accuracy while eliminating the time-consuming hydrolysis step.
Solution Approach 2:
The patent introduces an intermediary computational step where the total concentration is calculated by summing the detected metabolite concentrations and parent compound concentrations. This mathematical intermediary replaces the chemical hydrolysis process, achieving the same quantification goal without the time and complexity penalties of actual hydrolysis reactions.
2Reliability
If hydrolysis steps are used to convert metabolites back to parent compounds, then quantification reliability is improved, but device complexity and operational difficulty increase
Solution Approach 1:
The patent employs two specialized chromatographic columns with different stationary phases (HILIC and C18) that are each optimized for retaining specific analyte types. This segmentation allows the system to directly detect both metabolites and parent compounds in their native forms, eliminating the need for complex hydrolysis instrumentation and procedures while maintaining reliable quantification.
Solution Approach 2:
The patent creates a universal analysis system that can simultaneously handle both hydrophilic metabolites and less hydrophilic parent compounds in a single run. By using parallel chromatographic pathways with different column chemistries, the system achieves multi-functionality without requiring separate hydrolysis protocols or additional instrumentation, thereby reducing operational difficulty.
3Device complexity
If conventional single-column LCMS is used for analyzing hydrophilic metabolites, then device simplicity is maintained, but separation efficiency and measurement precision deteriorate
Solution Approach 1:
The patent segments the analyte detection into two parallel pathways: one using a HILIC column specifically optimized for hydrophilic metabolites and another using a C18 column for parent compounds. This segmentation ensures that each analyte type is analyzed by the most appropriate column chemistry, maintaining high measurement precision while keeping the overall system design relatively simple and modular.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables quick and reliable quantification of drug compounds without hydrolysis, reducing time, cost, and variability, and is suitable for routine clinical measurements in hospital labs, overcoming challenges with hydrophilic metabolites and parent compounds.
Implementation Method 1
Liquid chromatography mass spectrometry is a powerful analyte detection and measurement technique that has become the preferred method of detecting small molecule, amino acid, protein, peptide, nucleic acid, lipid, and carbohydrate analytes to a high accuracy for diagnostic purposes. The chromatographic separation process relies on the fact that a number of component solute molecules in a flowing stream of a fluid percolated through a packed bed of particles, known as the stationary phase, can be efficiently separated from one another.
Implementation Method 2
The individual sample components are separated because each component has a different affinity for the stationary phase, leading to a different rate of migration for each component and a different exit time for each component emerging from the column.
Implementation Method 3
Liquid chromatography mass spectrometry is a powerful analyte detection and measurement technique
Data Source
AI summary
A method for analyzing and quantifying a panel of drugs in a clinical sample comprises: trapping a first portion of drug parent compounds and their metabolites on a first chromatographic column; trapping a second portion of the drug parent compounds and their metabolites on a second chromatographic column; separately eluting the first and second portions of the drug parent compounds and their metabolites from the first and second chromatographic columns; detecting concentrations of each of the drug parent compounds and metabolites eluted from each of the first and second chromatographic columns with a detector; and summing the detected concentration of each drug parent compound together with the detected concentrations of all of its respective analytes so as to derive a respective total concentration of each drug in the sample.